Related Experiment Video
Updated: Apr 30, 2026

08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.1K
Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia
Peter J Puthenveetil1, Eyas M Hattab, Munro Peacock
1Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Summary
Oncogenic osteomalacia, a rare disorder caused by tumors, can manifest due to spinal tumors. This case highlights a patient with spinal tumor-induced oncogenic osteomalacia, emphasizing diagnosis and treatment.
Area of Science:
- Endocrinology
- Oncology
- Orthopedics
Background:
- Oncogenic osteomalacia is a rare paraneoplastic syndrome.
- It is typically induced by mesenchymal tumors, with over 100 cases reported.
- Spinal phosphaturic mesenchymal tumors are an exceptionally rare cause, accounting for only seven documented instances.
Observation:
- A 61-year-old woman presented with symptoms of oncogenic osteomalacia.
- The underlying cause was identified as a tumor of the spine.
- This case represents a rare occurrence of spinal phosphaturic mesenchymal tumors inducing the syndrome.
Findings:
- The patient's condition was successfully managed through surgical intervention.
- Literature review indicates surgical treatment is a primary approach for spinal tumors causing oncogenic osteomalacia.
- Comprehensive follow-up is crucial for managing patients with this rare condition.
Implications:
- This case underscores the importance of considering rare paraneoplastic syndromes in patients with unexplained bone disease.
- Early diagnosis and surgical management of spinal tumors are critical for treating oncogenic osteomalacia.
- Further research into phosphaturic mesenchymal tumors may improve understanding and treatment strategies for this rare disorder.
Keywords:
Fibroblast growth factorHypophosphatemiaOncogenic osteomalaciaParaneoplastic syndromePhosphaturic mesenchymal tumorThoracic spineMore Related Videos
Related Concept Videos
What is the Skeletal System?
45.7K
Overview
45.7K
Bone Remodeling
34.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
34.4K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Osteoclasts in Bone Remodeling
3.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Hormones and Bone Tissue
3.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K

